CStone Pharmaceuticals Share Price Deutsche Boerse AG
Stocks
PH4
KYG2588M1006
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
06:55:02 14/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.6174 EUR | -0.39% |
|
+22.60% | +8.32% |
| Market Cap | 789.14Cr 117.22Cr 101.5Cr 95Cr 86Cr 162.86Cr 11TCr 165.54Cr 1.11TCr 435.52Cr 5.6TCr 440.09Cr 430.5Cr 19TCr | P/E 2026 * |
-370x | P/E 2027 * | 7.37x |
|---|---|---|---|---|---|
| Enterprise Value | 736.32Cr 109.37Cr 95Cr 89Cr 81Cr 151.96Cr 10TCr 154.46Cr 1.04TCr 406.37Cr 5.23TCr 410.63Cr 401.68Cr 17TCr | EV / Sales 2026 * |
15.4x | EV / Sales 2027 * | 2.5x |
| Free-Float |
80.15% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CStone Pharmaceuticals
| 1 day | -0.39% | ||
| 1 week | +22.60% | ||
| Current month | +32.06% | ||
| 1 month | +14.59% | ||
| 3 months | -26.01% | ||
| 6 months | -0.42% | ||
| Current year | +8.32% |
| 1 week | 0.57 |  | 0.64 |
| 1 month | 0.45 | | 0.64 |
| Current year | 0.45 | | 1.12 |
| 1 year | 0.45 | | 1.35 |
| 3 years | 0.09 | | 1.35 |
| 5 years | 0.09 | | 1.55 |
| 10 years | 0.09 | | 1.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 25/08/2022 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 18/01/2023 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 01/08/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 25/08/2022 |
Edward Hu
BRD | Director/Board Member | 63 | 09/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.39% | +22.60% | - | - | 117.93Cr | |
| -0.31% | +4.06% | +43.08% | -0.43% | 8.05TCr | |
| -1.02% | +2.25% | -3.19% | +25.69% | 5.11TCr | |
| -3.10% | -5.64% | +11.56% | +158.84% | 4.82TCr | |
| -0.74% | +3.13% | -49.36% | -48.70% | 4.65TCr | |
| -0.39% | +1.72% | +55.21% | -23.33% | 3.11TCr | |
| -0.52% | +17.56% | +135.48% | -37.61% | 2.54TCr | |
| -0.30% | +1.50% | +39.97% | +82.25% | 2.44TCr | |
| -1.42% | +3.13% | -1.26% | +182.96% | 2.11TCr | |
| -1.83% | -1.21% | +59.91% | +107.34% | 1.63TCr | |
| Average | -1.00% | +3.52% | +32.38% | +49.67% | 3.83TCr | |
| Weighted average by Cap. | -1.02% | +2.96% | +25.11% | +36.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 48Cr 7.12Cr 6.17Cr 5.78Cr 5.25Cr 9.89Cr 679.33Cr 10Cr 68Cr 26Cr 340.3Cr 27Cr 26Cr 1.13TCr | 171.33Cr 25Cr 22Cr 21Cr 19Cr 35Cr 2.43TCr 36Cr 241.85Cr 95Cr 1.22TCr 96Cr 93Cr 4.05TCr |
| Net income | -24Cr -3.61Cr -3.13Cr -2.93Cr -2.66Cr -5.02Cr -344.69Cr -5.1Cr -34Cr -13Cr -172.67Cr -14Cr -13Cr -575.5Cr | 69Cr 10Cr 8.84Cr 8.29Cr 7.53Cr 14Cr 974.31Cr 14Cr 97Cr 38Cr 488.07Cr 38Cr 38Cr 1.63TCr |
| Net Debt | -53Cr -7.85Cr -6.79Cr -6.37Cr -5.78Cr -11Cr -748.61Cr -11Cr -75Cr -29Cr -375.01Cr -29Cr -29Cr -1.25TCr | -360.31Cr -54Cr -46Cr -43Cr -39Cr -74Cr -5.11TCr -76Cr -508.61Cr -198.85Cr -2.56TCr -200.94Cr -196.56Cr -8.53TCr |
| Date | Price | Change |
|---|---|---|
| 14/26/14 | €0.6174 | -0.39% |
| 13/26/13 | €0.6198 | -0.16% |
| 12/26/12 | €0.6208 | -2.60% |
| 11/26/11 | €0.6374 | +12.50% |
| 10/26/10 | €0.5666 | +0.93% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
- PH4 Stock
Select your edition
All financial news and data tailored to specific country editions
